Celther Polska

Celther Polska is a private Polish biotechnology and medical company focused on molecular biology, cell engineering, research-use cell models, wound-care medical devices, and regenerative skin-care products. The company develops and commercializes primary human cancer cell lines, genetically modified cell lines, induced pluripotent stem cells and differentiated derivatives for research, drug development, toxicity testing, and disease modeling. It also markets DibuCell wound dressings and CUDOCELL MAX and SHECELL regenerative dermatology/cosmetic products, leveraging its proprietary dibutyrylchitin-based biomaterial technology. Celther describes itself as having a strong in-house R&D base and has reported multiple patents and implemented R&D projects, including reimbursed DibuCell Active products in Poland. While it has referenced work on innovative anticancer and personalized/cell-therapy concepts, the clearest visible commercial offering today is its cell-model/services and wound-healing/skin-regeneration portfolio.